Disease Info Card

Candida Esophagitis

Information about Candida Esophagitis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Candida Esophagitis

Most recent studies have shown that Candida Esophagitis shares some biological mechanisms with acquired-immunodeficiency-syndrome, aids-related-opportunistic-infections, candidiasis, cytomegalovirus-infections, deglutition-disorders, esophageal-diseases, esophagitis, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, kaposi-sarcoma, mycoses, opportunistic-infections, oral-candidiasis, oropharyngeal-disorders, pneumonia, pneumonia-pneumocystis-carinii, sarcoma, tuberculosis, ulcer.

Among the many pathways, these few ones have gauged particular interests from scientists studying Candida Esophagitis, and have been seen in publications frequently: Cell Division, Cell Growth, Cell Proliferation, Commensalism, Drug Resistance, Excretion, Gastric Emptying, Hypersensitivity, Hyphal Growth, Immune Response, Inflammatory Response, Leukocyte Migration, Localization, Pathogenesis, Peristalsis, Phagocytosis, Reflex, Secretion, Tube Formation, Virulence

Quite a number of genes have been found to play important roles in Candida Esophagitis, such as ARC, BMP1, CD4, CD8A, COL18A1, CYP2C19, CYP2C9, CYP3A4, DEFB4A, EGFR, GNAI1, NDUFB6, NOL3, OXSM, PGPEP1, PRCP, QPCT, TMED2, TNFRSF10B. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.